Why do defects in the Fas-Fas ligand system cause autoimmunity?

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 6 SUPPL., 1997, Pages

  Suda, Takashi ^a   Nagata, Sigekazu ^a,b  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FAS ANTIGEN; FAS LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; T LYMPHOCYTE RECEPTOR;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL DEATH; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMUS;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNITY; CLONAL DELETION; FAS LIGAND PROTEIN; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; THYMUS GLAND;

EID: 0031398761     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(97)70013-7     Document Type: Article

References (46)

1. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol 1991;9:243-69.
2. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-7.
3. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 1993;90:1756-60.
4. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994;76:969-76.
5. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935-46.
6. Rieux-Laucat F, Le DF, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268:1347-9.
7. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
8. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 1993;75:1169-78.
9. Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995;154:3806-13.
10. + thymocytes by the anti-Fas antibody. J Exp Med 1995;181:485-91.
11. Watanabe D, Suda T, Nagata S. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int Immunol 1995;7:1949-56.
12. Rothstein TL, Wang JK, Panka DJ, et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995;374:163-5.
13. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-92.
14. + thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 1994;180:423-32.
15. Arase H, Arase N, Saito T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 1995;181:1235-8.
16. Hahne M, Renno T, Schroeter M, et al. Activated B cells express functional Fas ligand. Eur J Immunol 1996;26:721-4.
17. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995;377:630-2.
18. Steinberg AD, Roths JB, Murphy ED, Steinberg RT, Raveche ES. Effects of thymectomy or androgen administration upon the autoimmune disease of MKL/Mp-lpr/lpr mice. J Immunol 1980;125: 871-3.
19. Hang L, Theofilopoulos AN, Balderas RS, Francis SJ, Dixon FJ. The effect of thymectomy on lupus-prone mice. J Immunol 1984;132: 1809-13.
20. Wofsy D, Ledbetter JA, Hendler PL, Seaman WE. Treatment of murine lupus with monoclonal anti-T cell antibody. J Immunol 1985;134:852-7.
21. + T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J Exp Med 1988;167:1713-8.
22. Giese T, Davidson WF. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J Immunol 1994;152:2000-10.
23. Koh DR, Ho A, Rahemtulla A, Fung LW, Griesser H, Mak TW. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur J Immunol 1995;25:2558-62.
24. Christianson GJ, Blankenburg RL, Duffy TM, et al. Beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. J Immunol 1996;156:4932-9.
25. + double-negative T cells as the predominant populations in enlarged lymph nodes. J Immunol 1995;154:4986-95.
26. + cells in lpr/lpr mice lacking beta 2-microglobulin. J Immunol 1995;154:2063-74.
27. + T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules. Eur J Immunol 1995;25:37-41.
28. Maldonado MA, Eisenberg RA, Roper E, Cohen PL, Kotzin BL. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I, J Exp Med 1995;181:641-8.
29. Jevnikar AM, Grusby MJ, Glimcher LH. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med 1994;179:1137-43.
30. Eisenberg RA, Sobel ES, Reap EA, Halpern MD, Cohen PL. The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice. Semin Immunol 1994;6:49-54.
31. Perkins DL, Glaser RM, Mahon CA, Michaelson J, Marshak-Rothstein A. Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J Immunol 1990:145:549-55.
32. von Boehmer H, Kisielow P. Self-nonself discrimination by T cells. Science 1990:248:1369-73.
33. Suda T, Tanaka M, Miwa K, Nagata S. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J Immunol 1996;157:3918-24.
34. Herron LR, Eisenberg RA, Roper E, Kakkanaiah VN, Cohen PL, Kotzin BL. Selection of the T cell receptor repertoire in Lpr mice. J Immunol 1993;151:3450-9.
35. Singer GG, Abbas AK. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-71.
36. Sidman CL, Marshall JD, Von Boehmer H. Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur J Immunol 1992;22:499-504.
37. Mariani SM, Matiba B, Armandola EA, Krammer PH. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur J Immunol 1994;24:3119-23.
38. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
39. Adachi M, Suemura S, Suda T, et al. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci USA 1996;93:2131-6.
40. Russell JH, Rush B, Weaver C, Wang R. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 1993;90:4409-13.
41. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-l/(Fas/CD95). Nature 1995;373:438-41.
42. + T cells responding to a bacterial superantigen. J Immunol 1995;154:4302-8.
43. Scott DE, Kisch WJ, Steinberg AD. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J Immunol 1993;150:664-72.
44. Renno T, Hahne M, Tschopp J, MacDonald HR. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med 1996;183: 431-7.
45. + T cells. Nature 1995;376:181-4.
46. Nishimura Y, Ishii A, Kobayashi Y, Yamasaki Y, Yonehara S. Expression and function of mouse Fas antigen on immature and mature T cells. J Immunol 1995;154:4395-403.